| PERIOD ENDING | 30-Sep-09 | 30-Jun-09 | 31-Mar-09 | 31-Dec-08 | | Total Revenue | 8,132 | 9,249 | 9,624 | 9,267 | | Cost of Revenue | 2,138 | 2,228 | 2,476 | 2,734 | | | Gross Profit |
-
| 7,021 | 7,148 | 6,534 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 4,003 | 4,274 | 3,869 | 4,117 | | Non Recurring | 27,019 | 85 | 657 | 169 | | Others | 821 | 1,096 | 606 | 2,152 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss |
-
| 1,566 | 2,016 | 95 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (25,849) | 1,566 | 2,016 | 95 | | Interest Expense | 1,095 | 1,112 | 1,133 | 1,222 | | Income Before Tax | (26,944) | 454 | 883 | (1,126) | | Income Tax Expense | 141 | 40 | 311 | (638) | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | (27,085) | 414 | 572 | (488) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (27,085) | 414 | 572 | (488) | | Preferred Stock And Other Adjustments | (165) | (164) | (164) | (71) | | | Net Income Applicable To Common Shares | ($27,250) | $250 | $408 | ($559) |
|
0.03% Nasdaq 0.00%
Income Statement
